Follow
Deepak Cyril D'Souza
Deepak Cyril D'Souza
Yale university school of medicine
Verified email at Yale.edu
Title
Cited by
Cited by
Year
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis
DC D'Souza, E Perry, L MacDougall, Y Ammerman, T Cooper, Y Wu, ...
Neuropsychopharmacology 29 (8), 1558-1572, 2004
12772004
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction
DC D’Souza, WM Abi-Saab, S Madonick, K Forselius-Bielen, A Doersch, ...
Biological psychiatry 57 (6), 594-608, 2005
7912005
The acute effects of cannabinoids on memory in humans: a review
M Ranganathan, DC D’Souza
Psychopharmacology 188, 425-444, 2006
6572006
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development
JH Krystal, DC D'Souza, D Mathalon, E Perry, A Belger, R Hoffman
Psychopharmacology 169, 215-233, 2003
6092003
Clinical significance of neurological soft signs in schizophrenia: factor analysis of the Neurological Evaluation Scale
RA Sewell, EB Perry Jr, LP Karper, MD Bell, P Lysaker, JL Goulet, ...
Schizophrenia research 124 (1-3), 1-12, 2010
5632010
Gone to pot–a review of the association between cannabis and psychosis
R Radhakrishnan, ST Wilkinson, DC D’Souza
Frontiers in psychiatry 5, 72718, 2014
4612014
Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study
M Slifstein, E Van De Giessen, J Van Snellenberg, JL Thompson, ...
JAMA psychiatry 72 (4), 316-324, 2015
4102015
Cannabis and psychosis/schizophrenia: human studies
DC D’Souza, RA Sewell, M Ranganathan
European archives of psychiatry and clinical neuroscience 259, 413-431, 2009
3902009
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function
JH Krystal, EB Perry, R Gueorguieva, A Belger, SH Madonick, ...
Archives of general psychiatry 62 (9), 985-995, 2005
3862005
NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders
JH Krystal, DC D'Souza, IL Petrakis, A Belger, RM Berman, DS Charney, ...
Harvard review of psychiatry 7 (3), 125-143, 1999
3591999
N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability
JH Krystal, IL Petrakis, G Mason, L Trevisan, DC D'Souza
Pharmacology & therapeutics 99 (1), 79-94, 2003
3482003
Spicing things up: synthetic cannabinoids
M Spaderna, PH Addy, DC D’Souza
Psychopharmacology 228, 525-540, 2013
3462013
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II …
JH Krystal, W Abi-Saab, E Perry, DC D’Souza, N Liu, R Gueorguieva, ...
Psychopharmacology 179, 303-309, 2005
3312005
Blunted psychotomimetic and amnestic effects of Δ-9-tetrahydrocannabinol in frequent users of cannabis
DC D'souza, M Ranganathan, G Braley, R Gueorguieva, Z Zimolo, ...
Neuropsychopharmacology 33 (10), 2505-2516, 2008
3282008
Nicotine effects on brain function and functional connectivity in schizophrenia
LK Jacobsen, DC D'Souza, WE Mencl, KR Pugh, P Skudlarski, JH Krystal
Biological psychiatry 55 (8), 850-858, 2004
2852004
Interactive effects of subanesthetic ketamine and haloperidol in healthy humans
JH Krystal, DC D’Souza, LP Karper, A Bennett, A Abi-Dargham, ...
Psychopharmacology 145, 193-204, 1999
2851999
The NMDA antagonist model for schizophrenia: promise and pitfalls
WM Abi-Saab, DC D'souza, B Moghaddam, JH Krystal
Pharmacopsychiatry 31 (S 2), 104-109, 1998
2741998
Marijuana legalization: impact on physicians and public health
ST Wilkinson, S Yarnell, R Radhakrishnan, SA Ball, DC D'Souza
Annual review of medicine 67, 453-466, 2016
2382016
Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans
JH Krystal, LP Karper, A Bennett, DC D’Souza, A Abi-Dargham, ...
Psychopharmacology 135, 213-229, 1998
2381998
Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans
NR Driesen, G McCarthy, Z Bhagwagar, M Bloch, V Calhoun, DC D'Souza, ...
Molecular psychiatry 18 (11), 1199-1204, 2013
2352013
The system can't perform the operation now. Try again later.
Articles 1–20